Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a post on X:
“The future of oncology is bright.
One of the greatest privileges: educating the next generation.
Grateful to lead ESMO-ESCAT workshop with brilliant young oncologists. I love their curiosity, drive, and the best was the brilliant Q and A session.”
You can also read:
ESMO 2025 Day 1 Highlights Not to Miss
ESMO 2025 Day 2 Highlights Not to Miss
ESMO 2025 Day 3 Highlights Not to Miss
ESMO 2025 Day 4 Highlights Not to Miss
ESMO 2025 Day 5 Highlights Not to Miss
